4.5 Editorial Material

When you say Prostate, don't forget to say Bladder!

Journal

PROSTATE CANCER AND PROSTATIC DISEASES
Volume -, Issue -, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41391-023-00747-2

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate

Ekaterina Laukhtina, Marco Moschini, Wojciech Krajewski, Jeremy Yuen-Chun Teoh, Guillaume Ploussard, Francesco Soria, Florian Roghmann, Mara Anna Muenker, Mathieu Roumiguie, Mario Alvarez-Maestro, Vincent Misrai, Alessandro Antonelli, Alessandro Tafuri, Giuseppe Simone, Riccardo Mastroianni, Hongda Zhao, Razvan-George Rahota, David D'Andrea, Keiichiro Mori, Simone Albisinni, Pierre I. Karakiewicz, Harun Fajkovic, Dmitry Enikeev, Francesco Montorsi, Shahrokh F. Shariat, Benjamin Pradere

Summary: In patients undergoing simultaneous TURB and TURP, there is a lower recurrence rate and longer survival time compared to those who only undergo TURB, with no significant difference in adverse events.

BJU INTERNATIONAL (2023)

Article Oncology

Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma

Andrea Panunzio, Gabriele Sorce, Stefano Tappero, Lukas Hohenhorst, Cristina Cano Garcia, Mattia Piccinelli, Zhe Tian, Alessandro Tafuri, Ottavio De Cobelli, Felix K. H. Chun, Derya Tilki, Carlo Terrone, Alberto Briganti, Anil Kapoor, Fred Saad, Shahrokh F. Shariat, Maria Angela Cerruto, Alessandro Antonelli, Pierre I. Karakiewicz

Summary: Large-scale, contemporary, controlled analysis of mortality in metastatic collecting duct renal carcinoma are scarce. However, combination of cytoreductive nephrectomy and systemic therapy provide the lowest mortality rates in these patients.

CLINICAL GENITOURINARY CANCER (2023)

Article Urology & Nephrology

External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study

Ali Abdel Raheem, Isotta Landi, Ibrahim Alowidah, Umberto Capitanio, Francesco Montorsi, Alessandro Larcher, Ithaar Derweesh, Fady Ghali, Alexander Mottrie, Elio Mazzone, Geert De Naeyer, Riccardo Campi, Francesco Sessa, Marco Carini, Andrea Minervini, Jay D. Raman, Chris J. Rjepaj, Maximilian C. Kriegmair, Riccardo Autorino, Alessandro Veccia, Maria Carmen Mir, Francesco Claps, Young Deuk Choi, Won Sik Ham, Glen Denmer Santok, John Paul Tadifa, Justin Syling, Maria Furlan, Claudio Simeone, Maida Bada, Antonio Celia, Diego M. Carrion, Alfredo Aguilera Bazan, Cristina Ballesteros Ruiz, Manar Malki, Neil Barber, Muddassar Hussain, Salvatore Micali, Stefano Puliatti, Ahmed Ghaith, Ayman Hagras, Ayman M. Ghoneem, Ahmed Eissa, Abdulrahman Alqahtani, Abdullah Rumaih, Abdelaziz Alwahabi, Mohammed Jayed Alenzi, Nicola Pavan, Fabio Traunero, Alessandro Antonelli, Antonio Benito Porcaro, Ester Illiano, Elisabetta Costantini, Koon Ho Rha

Summary: In this study, the Yonsei nomogram was externally validated and shown to have good calibration properties in predicting the risk of CKD progression.

INTERNATIONAL JOURNAL OF UROLOGY (2023)

Article Urology & Nephrology

Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy

Satoshi Katayama, Benjamin Pradere, Nico C. Grossman, Aaron M. Potretzke, Stephen A. Boorjian, Alireza Ghoreifi, Sia Daneshmand, Hooman Djaladat, John P. Sfakianos, Andrea Mari, Zine-Eddine Khene, David D'Andrea, Nozomi Hayakawa, Alberto Breda, Matteo Fontana, Kazutoshi Fujita, Alessandro Antonelli, Thomas van Doeveren, Christina Steinbach, Keiichiro Mori, Ekaterina Laukhtina, Morgan Roupret, Vitaly Margulis, Pierre Karakiewicz, Motoo Araki, Eva Comperat, Yasutomo Nasu, Shahrokh F. Shariat

Summary: The technical limitations of ureteroscopic biopsy are believed to contribute to the high upgrading rate in upper tract urothelial carcinoma (UTUC). However, the impact of tumor specific factors on upgrading has not been investigated. This study found that high-grade and low-grade biopsy results on ureteroscopy are associated with different biological and clinical features of UTUC tumors.

INTERNATIONAL JOURNAL OF UROLOGY (2023)

Review Oncology

Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 cases

Savio Domenico Pandolfo, Francesco Del Giudice, Benjamin Chung, Celeste Manfredi, Marco De Sio, Rocco Damiano, Edward E. Cherullo, Cosimo De Nunzio, Giovanni E. Cacciamani, Luca Cindolo, Francesco Porpiglia, Vincenzo Mirone, Ciro Imbimbo, Riccardo Autorino, Fabio Crocerossa

Summary: This study provides a comprehensive analysis comparing the safety and effectiveness of robot-assisted simple prostatectomy (RASP) to open simple prostatectomy (OSP), laparoscopic simple prostatectomy (LSP), and laser enucleation of the prostate (EEP). The results reveal that RASP has better safety and functional outcomes in the treatment of bladder prostatic obstruction caused by large prostate glands.

PROSTATE CANCER AND PROSTATIC DISEASES (2023)

Article Oncology

Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate

Giampaolo Siena, Francesco Sessa, Luca Cindolo

Summary: In order to make Rezum treatment (RT) less invasive, we evaluated the advantages and feasibility of transurethral intraprostatic anesthesia (TUIA) via Schelin Catheter (TM) (SC). We included 20 men with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH), who underwent RT using TUIA via SC. The patients rated their pain prior to the procedure on a numeric rating scale (NRS) ranging from 0 to 10, with 0 indicating no pain and 10 indicating the worst pain. The median NRS score ranged from 0 to 3. No procedure-related complications were reported.

PROSTATE CANCER AND PROSTATIC DISEASES (2023)

Article Oncology

Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis

Francesco Barletta, Stefano Tappero, Andrea Panunzio, Reha-Baris Incesu, Cristina Cano Garcia, Mattia Luca Piccinelli, The Tian, Giorgio Gandaglia, Marco Moschini, Carlo Terrone, Alessandro Antonelli, Derya Tilki, Felix K. H. Chun, Ottavio De Cobelli, Fred Saad, Shahrokh F. Shariat, Francesco Montorsi, Alberto Briganti, Pierre I. Karakiewicz

Summary: The study aimed to assess the impact of event-free survival duration on cancer-specific mortality (CSM) in nonmetastatic muscle-invasive squamous cell carcinoma of the urinary bladder after radical cystectomy (RC). The researchers identified RC patients with this type of cancer through a database and analyzed their data using Cox regression models. The results showed that event-free status at 24 months was associated with significantly higher CSM-free survival compared to baseline predictions. This effect was most pronounced in patients with TanyN1-3 and T4N0, intermediate in T3N0, and still important but more modest in T2N0.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2023)

Article Oncology

Collecting duct carcinoma: Epidemiology, clinical characteristics and survival

Andrea Panunzio, Stefano Tappero, Lukas Hohenhorst, Cristina Cano Garcia, Mattia Piccinelli, Francesco Barletta, Zhe Tian, Alessandro Tafuri, Alberto Briganti, Ottavio De Cobelli, Felix K. H. Chun, Derya Tilki, Carlo Terrone, Anil Kapoor, Fred Saad, Shahrokh F. Shariat, Maria Angela Cerruto, Alessandro Antonelli, Pierre I. Karakiewicz

Summary: This study used a large population-based cohort to examine the epidemiology, clinical characteristics, and treatment of collecting duct carcinoma (CDC). The results showed that despite the poor prognosis of CDC, nephrectomy and systemic therapy have a significant positive effect on survival.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2023)

Article Immunology

COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

Laura Gragnani, Marcella Visentini, Serena Lorini, Stefano Angelo Santini, Gianfranco Lauletta, Cesare Mazzaro, Teresa Urraro, Luca Quartuccio, Fabio Cacciapaglia, Piero Ruscitti, Antonio Tavoni, Silvia Marri, Giuseppina Cusano, Luisa Petraccia, Caterina Naclerio, Elena Treppo, Giulia del Frate, Ilenia Di Cola, Vincenzo Raimondo, Daniela Scorpiniti, Monica Monti, Lorenzo Puccetti, Giusy Elia, Poupak Fallahi, Stefania Basili, Salvatore Scarpato, Florenzo Iannone, Milvia Casato, Alessandro Antonelli, Anna Linda Zignego, Clodoveo Ferri

Summary: This study investigated the prevalence and outcome of COVID-19 in a large series of MCs patients, as well as the safety and immunogenicity of COVID-19 vaccines. The results showed a significantly higher prevalence of COVID-19 in MCs patients compared to the general population, and the use of immunomodulators was associated with an increased risk of infection. Additionally, MCs patients with COVID-19 had a higher mortality rate, and older age was correlated with worse COVID-19 outcomes. The vaccination immunogenicity was impaired in MCs patients, and certain immunomodulators hindered the vaccine-induced immune response.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Oncology

Age represents the main driver of surgical decision making in patients candidate to radical cystectomy

Paolo Dell'Oglio, Stefano Tappero, Andrea Panunzio, Alessandro Antonelli, Daniel Salvador, Evanguelos Xylinas, Mario Alvarez-Maestro, Rodolfo Hurle, Rafael Sanchez Salas, Anna Colomer, Giuseppe Simone, Kees Hendricksen, Angelo Peroni, Chiara Lonati, Alberto Olivero, Morgan Roupret, Mathieu Roumiguie, Francesco Soria, Paolo Umari, David D'Andrea, Carlo Terrone, Antonio Galfano, Marco Moschini, Ettore Di Trapani

Summary: Age may influence the surgical approach, urinary diversion, and lymph node dissection in radical cystectomy for urothelial bladder cancer. This study tested the impact of age on surgical decision making and peri- and postoperative outcomes.

JOURNAL OF SURGICAL ONCOLOGY (2023)

Article Urology & Nephrology

The impact of 5-ARI on perioperative and functional outcomes of GreenLight PVP: an analysis of the Global GreenLight Group database

Tawfik Elsherbini, David Bouhadana, Iman Sadri, David-Dan Nguyen, Kyle W. Law, Adel Arezki, Claudia Deyirmendjian, Ahmed Ibrahim, Naeem Bhojani, Dean S. Elterman, Bilal Chughtai, Franck Bruyere, Luca Cindolo, Giovanni Ferrari, Carlos Vasquez-Lastra, Tiago Borelli-Bovo, Edgardo F. Becher, Hannes Cash, Maximillian Reimann, Enrique Rijo, Vincent Misrai, Kevin C. Zorn

Summary: In this study, the impact of 5-alpha reductase inhibitors (5-ARI) on the perioperative and functional outcomes of 180-Watt XPS GreenLight photovaporization of the prostate (PVP) was investigated. The findings suggest that preoperative 5-ARI is not associated with any clinically significant different perioperative or functional outcomes for GreenLight PVP.

CANADIAN JOURNAL OF UROLOGY (2023)

Meeting Abstract Urology & Nephrology

A novel outcomes categorization for current minimally invasive ejaculation-sparing treatments of benign prostatic hyperplasia: Results of a multicentric series

U. Anceschi, D. Amparore, G. Siena, A. Cocci, E. Checcucci, F. Prata, S. De Cillis, R. S. Flammia, A. Tufano, A. Quara, M. Ortenzi, A. Brassetti, A. M. Bove, G. Tuderti, S. D'Annunzio, L. Viola, F. Sessa, P. Spatafora, C. Fiori, F. Varvello, A. Minervini, G. Ferrari, F. Porpiglia, L. Cindolo, G. Simone

EUROPEAN UROLOGY (2023)

Meeting Abstract Urology & Nephrology

The impact of 5-alpha reductase inhibitors on perioperative and functional outcomes of Greenlight photovaporization of the prostate: An analysis of the Global Greenlight Group database

T. Elsherbini, D. Bouhadana, I Sadri, D-D Nguyen, K. W. Law, A. Arezki, C. Deyirmendjian, A. Ibrahim, K. Oumedjbeur, N. Bhojani, D. S. Elterman, B. Chughtai, F. Bruyere, L. Cindolo, G. Ferrari, C. Vasquez-Lastra, T. Borelli-Bovo, E. F. Becher, H. Cash, M. Reimann, E. Rijo, V Misrai, K. C. Zorn

EUROPEAN UROLOGY (2023)

Article Medicine, General & Internal

Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages

Cristina Cano Garcia, Andrea Panunzio, Stefano Tappero, Mattia Luca Piccinelli, Francesco Barletta, Reha-Baris Incesu, Kyle W. Law, Lukas Scheipner, Zhe Tian, Fred Saad, Shahrokh F. Shariat, Derya Tilki, Alberto Briganti, Ottavio De Cobelli, Carlo Terrone, Alessandro Antonelli, Severine Banek, Luis A. Kluth, Felix K. H. Chun, Pierre I. Karakiewicz

Summary: This study found differences between patients with pure embryonal carcinoma and mixed germ cell tumor in stages I, II, and III, with lower cancer-specific mortality in pure embryonal carcinoma patients. The presence of mixed germ cell tumor elements may be considered a risk factor for cancer-specific survival.

MEDICINA-LITHUANIA (2023)

Article Urology & Nephrology

Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome

Clara Cerrato, Savio Domenico Pandolfo, Riccardo Autorino, Andrea Panunzio, Alessandro Tafuri, Antonio Benito Porcaro, Alessandro Veccia, Vincenzo De Marco, Maria Angela Cerruto, Alessandro Antonelli, Ithaar H. Derweesh, Maria Carmen Mir Maresma

Summary: This review provides a gender-specific clinical guide on diagnosis, screening, surveillance, and counseling for UTUC patients with Lynch syndrome. It highlights the different effects and penetrance of gene mutations between males and females. It suggests that urologists should be aware of the association between MMR mutations and different malignancies based on gender.

WORLD JOURNAL OF UROLOGY (2023)

No Data Available